B
Bull
Bull · 25%SXTC
$2.24
情景价格
$2.220
-0.217 (-9.76%)收盘时
Loading chart…
- High
- 2.500
- Open
- 2.500
- VWAP
- 2.26
- Vol
- 106.51K
- Mkt Cap
- 1.01M
- Low
- 2.060
- Amount
- 240.71K
- EV/EBITDA, TTM
- 0.00
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.
AI analysis of China SXT Pharmaceuticals Inc (SXTC)
sellGiven the current price of $3.00 and an RSI of 23.016, which indicates that the stock is oversold, SXTC does not present a good buying opportunity right now. The stock has experienced a staggering 99.99% decline year-to-date, reflecting severe underlying issues. Additionally, the recent reverse stock split and subsequent price drop of nearly 30% raise significant concerns about the company's stability and future prospects.
估值指标
The current forward P/E ratio for China SXT Pharmaceuticals Inc (SXTC) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for SXTC
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
事件时间线
资讯
8.507-24NewsfilterChina SXT Pharmaceuticals Closes $9 Million Direct Offering
8.507-23seekingalphaChina SXT Pharmaceuticals Secures $9M Direct Offering
9.502-02BenzingaDarkIris Inc Reports 27.3% Revenue Growth, Shares Surge
2.001-30stocktwitsChina SXT Pharmaceuticals Announces 1-for-150 Reverse Stock Split to Boost Share Price
- 8.501-30seekingalpha
China SXT Pharmaceuticals Announces 1-for-150 Share Consolidation
SXTC FAQ — answered by Alphio AI
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
Given the current price of $3.00 and an RSI of 23.016, which indicates that the stock is oversold, SXTC does not present a good buying opportunity right now. The stock has experienced a staggering 99.99% decline year-to-date, reflecting severe underlying issues. Additionally, the recent reverse stock split and subsequent price drop of nearly 30% raise significant concerns about the company's stability and future prospects.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。